BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15952021)

  • 1. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs.
    Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.
    Johnell K; Fastbom J
    Clin Drug Investig; 2008; 28(11):687-95. PubMed ID: 18840011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of SSRIs, NSAIDs/aspirin and gastroprotective drugs among residents of long-term care facilities: a medical record review.
    Bell JS; Taipale HT; Soini H; Pitkälä KH
    Clin Drug Investig; 2011; 31(5):337-44. PubMed ID: 21366362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
    Warlé-van Herwaarden MF; Koffeman AR; Valkhoff VE; 't Jong GW; Kramers C; Sturkenboom MC; De Smet PA
    Br J Clin Pharmacol; 2015 Sep; 80(3):589-98. PubMed ID: 25777983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding.
    Lee MT; Park KY; Kim MS; You SH; Kang YJ; Jung SY
    Yonsei Med J; 2020 Sep; 61(9):741-749. PubMed ID: 32882758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.
    Anglin R; Yuan Y; Moayyedi P; Tse F; Armstrong D; Leontiadis GI
    Am J Gastroenterol; 2014 Jun; 109(6):811-9. PubMed ID: 24777151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population.
    Helin-Salmivaara A; Huttunen T; Grönroos JM; Klaukka T; Huupponen R
    Eur J Clin Pharmacol; 2007 Apr; 63(4):403-8. PubMed ID: 17347805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Gastrointestinal Bleeding with Concurrent Use of NSAID and SSRI: A Systematic Review and Network Meta-Analysis.
    Haghbin H; Zakirkhodjaev N; Husain FF; Lee-Smith W; Aziz M
    Dig Dis Sci; 2023 May; 68(5):1975-1982. PubMed ID: 36526813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study.
    Valkhoff VE; van Soest EM; Masclee GM; de Bie S; Mazzaglia G; Molokhia M; Kuipers EJ; Sturkenboom MC
    Aliment Pharmacol Ther; 2012 Oct; 36(8):790-9. PubMed ID: 22928490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing of gastroprotective drugs among elderly NSAID users in The Netherlands.
    van Dijk KN; ter Huurne K; de Vries CS; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Pharm World Sci; 2002 Jun; 24(3):100-3. PubMed ID: 12136741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
    Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers.
    Lallana MJ; Feja C; Aguilar-Palacio I; Malo S; Rabanaque MJ
    Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30149590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous co-prescription of rebamipide prevents upper gastrointestinal bleeding in NSAID use for orthopaedic conditions: A nested case-control study using the LIFE Study database.
    Yamate S; Ishiguro C; Fukuda H; Hamai S; Nakashima Y
    PLoS One; 2024; 19(6):e0305320. PubMed ID: 38861561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptions.
    Pasina L; Nobili A; Tettamanti M; Riva E; Lucca U; Piccinelli R; Defendi L; Perego L; Lucifora S; Bulla C
    Int J Clin Pharmacol Ther; 2010 Nov; 48(11):735-43. PubMed ID: 20979932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy.
    Silvani MC; Motola D; Poluzzi E; Bottoni A; De Ponti F; Vaccheri A; Montanaro N
    Eur J Clin Pharmacol; 2006 Mar; 62(3):235-41. PubMed ID: 16416304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
    Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding.
    Ahsberg K; Höglund P; Kim WH; von Holstein CS
    Scand J Gastroenterol; 2010 Dec; 45(12):1404-15. PubMed ID: 20695720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.